5-Amino-1MQ vs MOTS-c
Research Verdict
Neither compound has a universal evidence advantage. Research distinction: NNMT-specific metabolic research or NAD+ pathway studies vs. Mitochondrial biology, AMPK signaling, or exercise-mimetic research where MOTS-c has broader indepen.
Quick Answers
Which is better, 5-Amino-1MQ or MOTS-c?
Neither compound has a universal evidence advantage. Research distinction: NNMT-specific metabolic research or NAD+ pathway studies vs. Mitochondrial biology, AMPK signaling, or exercise-mimetic research where MOTS-c has broader indepen.
What is the key difference between 5-Amino-1MQ and MOTS-c?
MOTS-c is an endogenous mitochondrial-derived peptide acting via AMPK activation and metabolic homeostasis; 5-Amino-1MQ is a synthetic NNMT inhibitor - endogenous signaling molecule vs. enzyme inhibitor.
Evidence Comparison
MOTS-c: identified in 2015 (Lee et al. Cell Metab 2015) as a mitochondrial-derived peptide, with multiple independent groups studying its AMPK-mediated metabolic effects in animal models. 5-Amino-1MQ: single research group, mouse data only. MOTS-c has broader independent validation but neither has human efficacy trials.
Evidence Context Favoring 5-Amino-1MQ
NNMT-specific metabolic research or NAD+ pathway studies.
Evidence Context Favoring MOTS-c
Mitochondrial biology, AMPK signaling, or exercise-mimetic research where MOTS-c has broader independent characterization.
Side-by-Side Snapshot
| Evidence grade | 5-Amino-1MQ: Level D MOTS-c: Level D |
|---|---|
| Research status | 5-Amino-1MQ: Preclinical MOTS-c: Preclinical |
| Primary category | 5-Amino-1MQ: Weight Loss & Metabolic MOTS-c: Anti-Aging & Longevity |
| Cited studies | 5-Amino-1MQ: 2 MOTS-c: 3 |